FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma

BACKGROUND: Segmental genomic copy number alterations, such as loss of 11q or 3p and gain of 17q, are well established markers of poor outcome in neuroblastoma, and have been suggested to comprise tumor suppressor genes or oncogenes, respectively. The gene forkhead box P1 (FOXP1) maps to chromosome...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Cancer
Main Authors: Ackermann, Sandra, Kocak, Hayriye, Hero, Barbara, Ehemann, Volker, Kahlert, Yvonne, Oberthuer, André, Roels, Frederik, Theißen, Jessica, Odenthal, Margarete, Berthold, Frank, Fischer, Matthias
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4251948/
https://ncbi.nlm.nih.gov/pubmed/25406647
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-840
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados